FI891552A0 - Anti-inflammatorisk emulsionssalvakomposition. - Google Patents

Anti-inflammatorisk emulsionssalvakomposition.

Info

Publication number
FI891552A0
FI891552A0 FI891552A FI891552A FI891552A0 FI 891552 A0 FI891552 A0 FI 891552A0 FI 891552 A FI891552 A FI 891552A FI 891552 A FI891552 A FI 891552A FI 891552 A0 FI891552 A0 FI 891552A0
Authority
FI
Finland
Prior art keywords
alpha
inflammatorisk
emulsionssalvakomposition
furoate
elegant
Prior art date
Application number
FI891552A
Other languages
English (en)
Other versions
FI100047B (fi
FI891552A (fi
Inventor
Farah Joseph Munayyer
Joel August Sequeira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI891552A publication Critical patent/FI891552A/fi
Publication of FI891552A0 publication Critical patent/FI891552A0/fi
Application granted granted Critical
Publication of FI100047B publication Critical patent/FI100047B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Semiconductor Memories (AREA)
  • Insulated Gate Type Field-Effect Transistor (AREA)
FI891552A 1986-10-02 1989-03-31 Menetelmä stabiilin tooppisen farmaseuttisen seoksen valmistamiseksi FI100047B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/914,227 US4808610A (en) 1986-10-02 1986-10-02 Mometasone furoate anti-inflammatory cream composition using hexylene glycol
PCT/US1987/002470 WO1988002257A1 (en) 1986-10-02 1987-10-01 Anti-inflammatory cream composition

Publications (3)

Publication Number Publication Date
FI891552A FI891552A (fi) 1989-03-31
FI891552A0 true FI891552A0 (fi) 1989-03-31
FI100047B FI100047B (fi) 1997-09-15

Family

ID=25434063

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891552A FI100047B (fi) 1986-10-02 1989-03-31 Menetelmä stabiilin tooppisen farmaseuttisen seoksen valmistamiseksi

Country Status (22)

Country Link
US (1) US4808610A (fi)
EP (2) EP0262681B1 (fi)
JP (1) JPH0643317B2 (fi)
KR (2) KR930010585B1 (fi)
AT (1) ATE62815T1 (fi)
AU (1) AU603837B2 (fi)
CA (1) CA1294877C (fi)
DE (1) DE3769568D1 (fi)
DK (1) DK174790B1 (fi)
ES (1) ES2038643T3 (fi)
FI (1) FI100047B (fi)
GR (1) GR3002086T3 (fi)
HK (1) HK102593A (fi)
IE (1) IE60492B1 (fi)
IL (1) IL84055A (fi)
MX (1) MX9203395A (fi)
NO (1) NO175350C (fi)
NZ (1) NZ222020A (fi)
OA (1) OA09034A (fi)
PH (1) PH23440A (fi)
WO (1) WO1988002257A1 (fi)
ZA (1) ZA877401B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1308664C (fr) * 1987-09-23 1992-10-13 Paul Thau Composition de traitement de la peau sous forme de mousse aerosol contenant de la vaseline (marque de commerce)
US5223340A (en) * 1989-04-20 1993-06-29 Peach State Labs, Inc. Stain resistant polyamide fibers
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
AU663471B2 (en) 1990-09-10 1995-10-12 Merck Sharp & Dohme Corp. Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
US6127353A (en) * 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
US5407678A (en) * 1993-09-01 1995-04-18 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Petroleum jelly cream
AU701833B2 (en) * 1993-12-21 1999-02-04 Merck Sharp & Dohme Corp. Psoriasis treatment
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
AU5303899A (en) * 1998-08-26 2000-03-21 Shionogi & Co., Ltd. Anti-inflammatory ointments
FR2787025B1 (fr) * 1998-12-14 2002-10-11 Oreal Composition sous forme d'emulsion h/e a forte teneur en cire et ses utilisations dans les domaines cosmetique et dermatologique
US7897976B2 (en) 2002-02-19 2011-03-01 Hoya Corporation Light-emitting device of field-effect transistor type
US7312207B2 (en) 2003-05-23 2007-12-25 Taro Pharmaceuticals North America, Inc. Topical steroid cream formulations
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EP2120868A4 (en) * 2007-04-11 2010-08-25 Perrigo Israel Phamaceuticals LOW-DOSED MOMETASON FORMULATIONS
US20080311058A1 (en) * 2007-06-18 2008-12-18 Connopco, Inc., D/B/A Unilever Stable high internal phase emulsions and compositions comprising the same
WO2009063493A2 (en) * 2007-09-10 2009-05-22 Glenmark Pharmaceuticals Limited Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
US20090082318A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched mometasone
NZ591093A (en) * 2008-10-30 2012-02-24 Ego Pharmaceuticals Pty Ltd Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
CN102458382B (zh) 2009-05-12 2015-03-18 咖勒尼卡公司 莫米松和丙二醇的水包油乳状液
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate
US20110305649A1 (en) * 2010-06-14 2011-12-15 Conopco, Inc., D/B/A Unilever High Humectant High Internal Phase Emulsion
US8821839B2 (en) 2010-10-22 2014-09-02 Conopco, Inc. Compositions and methods for imparting a sunless tan with a vicinal diamine
US8398959B2 (en) 2010-12-06 2013-03-19 Conopco, Inc. Compositions and methods for imparting a sunless tan with functionalized adjuvants
US8961942B2 (en) 2011-12-13 2015-02-24 Conopco, Inc. Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
RU2548764C2 (ru) * 2013-01-25 2015-04-20 Открытое Акционерное Общество "Татхимфармпрепараты" Лекарственное средство для лечения дерматозов (варианты)
US9744122B2 (en) * 2013-04-29 2017-08-29 Helene Bertrand Topical formulation for pain relief
JP2015196663A (ja) * 2014-04-01 2015-11-09 ロレアル ナノ又はマイクロエマルションの形態の組成物
FR3039399B1 (fr) * 2015-07-31 2018-08-24 Idl International Drug Licensing Creme pour l'admnistration de steroides et son procede de preparation
JP6982293B2 (ja) * 2017-07-25 2021-12-17 株式会社大阪製薬 皮膚外用組成物
EP4199902A1 (en) * 2020-08-20 2023-06-28 Pfizer Inc. Stable topical formulations of 1(r)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol
WO2024133039A1 (en) 2022-12-20 2024-06-27 Galenica Derma Ab Novel composition for local skin treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048310A (en) * 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid formulation in form of lotion or cream
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
US4124707A (en) * 1976-12-22 1978-11-07 Schering Corporation 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor
US4083974A (en) * 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
US4201778A (en) * 1977-11-08 1980-05-06 Schering Corporation 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates
US4267173A (en) * 1979-11-05 1981-05-12 Schering Corporation Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
JPS59137408A (ja) * 1983-01-27 1984-08-07 Taisho Pharmaceut Co Ltd 軟膏
US4489071A (en) * 1983-12-09 1984-12-18 Schering Corporation Betamethasone dipropionate cream

Also Published As

Publication number Publication date
MX9203395A (es) 1992-07-01
FI100047B (fi) 1997-09-15
NO882417L (no) 1988-06-01
DK295088D0 (da) 1988-05-31
IE60492B1 (en) 1994-07-27
NZ222020A (en) 1990-03-27
WO1988002257A1 (en) 1988-04-07
GR3002086T3 (en) 1992-12-30
EP0262681B1 (en) 1991-04-24
FI891552A (fi) 1989-03-31
DE3769568D1 (de) 1991-05-29
US4808610A (en) 1989-02-28
HK102593A (en) 1993-10-08
EP0318522A1 (en) 1989-06-07
OA09034A (en) 1991-03-31
NO175350B (no) 1994-06-27
ATE62815T1 (de) 1991-05-15
PH23440A (en) 1989-08-07
IL84055A0 (en) 1988-03-31
ES2038643T3 (es) 1993-08-01
ZA877401B (en) 1988-05-25
NO175350C (no) 1994-10-05
EP0262681A1 (en) 1988-04-06
JPH0643317B2 (ja) 1994-06-08
JPH02500976A (ja) 1990-04-05
KR930010585B1 (ko) 1993-10-30
NO882417D0 (no) 1988-06-01
IE872633L (en) 1988-04-02
DK295088A (da) 1988-05-31
KR880701555A (ko) 1988-11-03
AU603837B2 (en) 1990-11-29
IL84055A (en) 1991-09-16
AU8071287A (en) 1988-04-21
CA1294877C (en) 1992-01-28
DK174790B1 (da) 2003-11-17

Similar Documents

Publication Publication Date Title
FI891552A (fi) Anti-inflammatorisk emulsionssalvakomposition.
IT8667371A1 (it) Composizioni topiche per il trattamento della pelle a base di derivati dell'acido salicilico.
DE2965284D1 (en) Pharmaceutical compositions for topical administration containing prostaglandins
EG17753A (en) Novel pharmacological compounds
DK581185D0 (da) Farmaceutisk praeparat indeholdende 13-cis-a-vitaminsyre
IT7947717A0 (it) Formulazione farmaceutica a base di acido(tutto-z)-5,8,11,14,17-eicosa pentaenoico
ES2032898T5 (es) Locion de esteroide.
IT8219947A0 (it) Complessi platino-diamminici eprocedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi.
IT8221278A0 (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
ZA91115B (en) Topical compositions
MX9204815A (es) Hexahidrobenzo[f]quinolinonas y formulacion farmaceutica que las comprende.
ATE22005T1 (de) Cremegrundlage.
AU570638B2 (en) Corticoid formulations
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
AU517208B2 (en) Animal "pled ingredient
NZ189211A (en) 1,4-cyclohexadiene carboxylic acid derivatives and pharmaceutical compositions
IT8521622A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo acetil -10triacetossi-1,8,9 antracene.
IT7920770A0 (it) Composizioni dermatologiche a basedi derivati dell'acido mercaptopropionammido-acetico.
IT8622172A0 (it) Composizioni antiinfiammatorie topiche.

Legal Events

Date Code Title Description
FD Application lapsed
FG Patent granted

Owner name: SCHERING CORPORATION

MA Patent expired